http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2008150485-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-18 |
filingDate | 2007-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2010-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2008150485-A |
titleOfInvention | SUBSTITUTED PYRAZINONE DERIVATIVES FOR USE AS A MEDICINAL PRODUCT |
abstract | 1. The compound of General formula (I)! ! its pharmaceutically acceptable acid or base addition salt, its N-oxide form or its quaternary ammonium salt, where! Y is a divalent radical of formula (II)! ! where A is a nitrogen or carbon atom; ! m is an integer equal to zero, 1 or 2; and! Z is a covalent bond or N-R4; wherein R4 is selected from the group consisting of hydrogen, (C1-3) alkyl and phenylcarboxyl (C1-3) alkyl; ! R5 is selected from the group consisting of hydrogen and halogen; ! R7 is selected from the group consisting of hydrogen, (C1-3) alkyl; (C1-3) alkyloxy groups; halogen; cyano groups; nitro groups; formyl; ethanoyl; hydroxy groups; amino groups; trifluoromethyl; mono- and di ((C1-3) alkyl) amino groups; mono- and di ((C1-3) alkylcarbonyl) amino groups; carboxyl; morpholinyl and thio groups; and r is an integer equal to zero, 1, 2, 3, 4 or 5; ! X1, X2, each independently of one another, means a bond, a saturated or unsaturated (C1-8) hydrocarbon radical, where one or more divalent -CH2 units may optionally be replaced with the corresponding divalent phenyl unit; and where one or more hydrogen atoms can be replaced by a radical selected from the group consisting of an oxo group; (C1-3) alkyloxy groups; halogen; cyano groups; nitro groups; formyl; hydroxy groups; amino groups; trifluoromethyl; mono- and di ((C1-3) alkyl) amino groups; carboxyl and thio groups; ! Q1, Q2, each independently of one another, means a radical selected from the group consisting of hydrogen; -NR1R2; Pir -OR3a; SR3b; SO2R3c; aryl and het; however, two -OR3a radicals taken together can form a divalent radical -O- (CH2) s-O-, where s is an integer equal to 1, 2 or 3; ! p, q, each independently different |
priorityDate | 2006-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.